⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026
The Dispatch

NSE

Natco Pharma LimitedNATCOPHARM

Nifty Smallcap 250

Natco Pharma Limited is an NSE-listed company (NATCOPHARM).

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Interim Dividend - Rs 1.50 Per Share

ex 2026-02-18

Competitive landscape — the read

vs mapped peers
Institutional money is backing ACUTAAS hardest (+₹98.2 Cr net). NATCOPHARM ranks #3 of 9 on flow (net buying +₹0 Cr). Filing momentum favours ABFRL (+1). News & social buzz is most positive on ACUTAAS.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ACUTAAS+₹98.2 Cr1——+46
2AAVAS+₹79.7 Cr5————
3NATCOPHARMThis+₹0 Cr6————
4AADHARHFC——————
5AARTIIND+₹0 Cr4————
6ACE+₹0 Cr2————
7ACMESOLAR−₹80.9 Cr1——+36
8ABLBL−₹314.4 Cr29————
9ABFRL−₹730.3 Cr13—+1——

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — NATCOPHARM day by day

  1. 2026-02-18ActionInterim Dividend - Rs 1.50 Per ShareDividend
  2. 2025-11-26BulkBUY · ₹108.4 CrGRAVITON RESEARCH CAPITAL LLP
  3. 2025-11-26BulkSELL · ₹108.5 CrGRAVITON RESEARCH CAPITAL LLP
  4. 2025-11-20ActionInterim Dividend - Rs 1.50 Per ShareDividend
  5. 2025-08-19ActionInterim Dividend - Rs 2 Per ShareDividend
  6. 2025-04-24BulkSELL · ₹166 CrGRAVITON RESEARCH CAPITAL LLP
  7. 2025-04-24BulkBUY · ₹165.9 CrGRAVITON RESEARCH CAPITAL LLP
  8. 2025-02-18ActionInterim Dividend - Rs 1.50 Per ShareDividend
  9. 2025-02-14BulkBUY · ₹86.6 CrGRAVITON RESEARCH CAPITAL LLP
  10. 2025-02-14BulkSELL · ₹86.6 CrGRAVITON RESEARCH CAPITAL LLP
  11. 2024-11-27ActionInterim Dividend - Rs 1.50 Per ShareDividend
  12. 2024-09-25ActionAnnual General MeetingMeeting
  13. 2024-08-23ActionInterim Dividend - Rs 3 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

No scored filings for NATCOPHARM yet.

Bulk & block deals

1M3M6M1Y2YAll

6 deals · 2025-02-14 → 2025-11-26

DateCounterpartyInvestor typeSideValue
2025-11-26GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹108.4 Cr
2025-11-26GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹108.5 Cr
2025-04-24GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹166 Cr
2025-04-24GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹165.9 Cr
2025-02-14GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹86.6 Cr
2025-02-14GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹86.6 Cr

6 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on NATCOPHARM

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.